SPY295.44+0.56 0.19%
DIA244.88-0.14 -0.06%
IXIC9,324.59+39.71 0.43%

WAVE Life Sciences Q4 EPS $(1.65) Misses $(1.43) Estimate, Sales $2.4M Miss $5.52M Estimate

WAVE Life Sciences (NASDAQ:WVE) reported quarterly losses of $(1.65) per share which missed the analyst consensus estimate of $(1.43) by 15.38 percent. This is a 28.91 percent decrease over losses of $(1.28) per share

Benzinga · 03/02/2020 11:50

WAVE Life Sciences (NASDAQ:WVE) reported quarterly losses of $(1.65) per share which missed the analyst consensus estimate of $(1.43) by 15.38 percent. This is a 28.91 percent decrease over losses of $(1.28) per share from the same period last year. The company reported quarterly sales of $2.4 million which missed the analyst consensus estimate of $5.52 million by 56.52 percent. This is a 33.70 percent decrease over sales of $3.62 million the same period last year.